A biotech superstar with UNTHSC roots
By Jan Jarvis
Six years ago in an acceleration lab at UNT Health Science Center, the co-founders of ZS Pharma were developing a drug that they believed held great promise. But even with such lofty expectations, ZS Pharma co-founders Alvaro Guillem and Jeff Keyser may have underestimated their biotech startup’s potential.
Earlier this month British drug maker AstraZeneca agreed to acquire ZS Pharma for $2.7 billion in cash.
In the pharmaceutical world – where it typically takes a decade or more to move a drug from bench to bedside – ZS Pharma has moved at lightning speed. UNT Health Science Center helped make it all possible by providing offices, conference rooms and a lab where much of the work was done, Guillem said.
“During the early years it was critical to have the support of institutions like UNTHSC and the accelerator labs to be able to move the project forward,” Guillem said. “To this day, we continue to collaborate with labs and rely on their equipment and expertise to address various technical topics.”
From the start, ZS Pharma had all the making of a biotech superstar. Founded in 2008, it debuted on Wall Street as the first biotech IPO in Texas since 2000. Its drug, called ZS-9, has been on the fast track from the start.
Multiple clinical trials have shown the effectiveness of the drug, which is expected to hit the market in 2016. It treats hyperkalemia, a potentially life-threatening disease caused by excess potassium. About one in 200,000 people have the condition, which often affects people with chronic kidney disease and chronic heart failure.
Since 2006, UNT Health Science Center’s Office of Research Development and Commercialization and TECH Fort Worth, a non-profit technology incubator, have worked in partnership to bring new technologies to the market.
Firms get a boost from the UNTHSC Accelerator Lab Program along with the Executives-in-Residence, who act as mentors and offer advice from their years of experience in the pharmaceutical industry.
Taking research to the marketplace can be an arduous process. Playing a part in getting this drug on the path to patients has been rewarding for everyone involved , said Lawrence “Joe” Allred, Associate Vice President for Research and Innovation at UNTHSC.
“We can rightfully take pride in ZS Pharma’s success as a graduation of incubation in our Accelerator Labs,” he said.
By Jan Jarvis Nearly a quarter of UNT System College of Pharmacy students took a day off from their classes to get a lesson in advocacy. The students joined nearly 600 pharmacy professionals from throughout the state for Pharmacist Day at the Capitol in Austin. The Texas Pharma...Read more
Mar 21, 2019
By Rebecca Najera High school juniors and seniors have the chance to show off their artistic skills at the UNT Health Science Center when the annual High School Art Show opens in the Atrium Gallery April 5. Brock ISD art teacher Sue Brunner has been submitting her students’ work to the art s...Read more
Mar 20, 2019
By Sally Crocker A team of UNTHSC researchers has recently completed a comprehensive community assessment for United Way of Tarrant County that will help set the organization’s strategic direction for years to come. Findings from this extensive study, which uncovered some of the m...Read more
Mar 19, 2019
By Jan Jarvis Under soft green lights, Isadora Cabral jumped into the arms of a classmate as soon as she opened her Match Day envelope. “It’s amazing, emotional, so great and exciting,” Cabral said. “I applied to way too many programs, but I got my No. 1.” Cabral will soon...Read more
Mar 18, 2019